PEG-rhG-CSF in Patients With Malignant Solid Tumors Receiving Chemotherapy
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to estimate the safety and efficacy of PEG-rhG-CSF in patients
with lung cancer,head and neck cancer,colorectal cancer,and ovarian cancer receiving
multi-cycle chemotherapy.